Jeddah 11 and a man in New Jersey joined a growing chorus for the users of the famous weight-weight drugs, Osmt and Wigvovi, who say they did not lose fat-they lost their eyesight as well.
The new local claims submitted by the husband claim that the manufacturer has hidden the “devastating” risks, which she left with constant loss of life in both eyes.
“It is painful to think that I will not be able to see my grandchildren's faces and a fully experienced experience of my loved ones,” Prosecutor Celit Mitchell, 64 -year -old grandmother and former vice president on a large commercial bank in California.
“If I knew OzemPIC would take my vision, I will never take it.”
Danish drug maker Novo Nordsek is accused in claims of “deceptive and misleading on the real risks” of successful GLP-1 obesity, as legal documents indicate multiple studies indicating that the possibility of “eye strikes” that pass blindly with their use.
Claims insist that the manufacturer bears the responsibility for warning doctors and users “of complications and destructive effects” – which is so popular that it is so popular that it is more than $ 25 billion in global sales last year.
But Novo Nordisk “failed” to communicate “clinically relevant information” with a risk of irreversible blindness, as claims claim.
Patients of vision filed lawsuits against the pharmaceutical maker in the New Jersey State Court last week. The company's headquarters in the United States in PlainsBoro, New Jersey.
Both prosecutors said in their allowances that they started taking medications that lose weight in 2023, in addition to losing some weight, noting that they were not alleviating after months of the first injection.
Mitchell, a mother of four years, said that she began to notice “cloudy dark shades” in her right eye only three months after her system, first with Wigofi, then Olzambich.
She said that the ophthalmologist urged her to rush to the emergency room to obtain magnetic resonance imaging, as she was diagnosed with illegal illegal optic neuropathy, or Nayoun, in her right eye.
She said that things are increasing for weeks on Easter on Sunday.
“While playing with my grandchildren, dark clouds began to infiltrate into my other eyes,” Mitchell said.
“The next day, the doctor confirmed that I developed NAION in that eye as well, with a permanent result of vision.”
Mitchell, who was close to retirement, began taking lessons at the San Diego Center for the Blind to see if she would be able to return to her job in the bank – as she is no longer able to see a computer screen.
But NAION's vision and balance issues have completely stopped the work, as its insight says.
“I now need help in doing daily activities and mobility in life,” Mitchell said.
The New Jersey patient, who declined to comment on this position, claims that he was diagnosed with the NAION of NAION, about a month after he had problems with his vision.
The man says in his suit that “he can no longer drive, he can no longer read, and he completely depends on his wife for daily help.”
The nervous ophthalmologist told him that his vision would never recover, according to the court document.
The medicine maker said in a statement to the position that the condition of seeing users, NAION, “rare” and “not a negative drug reaction” of its products.
The manufacturer of its internal studies and research from the University of South Denmark cited the claim.
“Novo Nordsk sees the profile at risk [the alleged culprit ingredient] The company's representative told The Post.
But Craig Silverman, the lawyer for the sick, said that the prosecutors “strongly reject the attempt to reject Novo Nordisk to reduce the dangerous risks associated with weight loss drugs.”
The two invitations cite studies that claim NAION's bonds of drugs, including the 2024 research published in the American Medical Association.
The study found that drug users were more likely to develop NAION, but they also notice more search for causation.
Claims indicate that “Drugmaker's warning posters are still free of any mention of NAION.”
Other former users also provided weight loss drugs against the drug maker who claims that the GLP-1 drugs have also caused NAION.
